Company intelligence / Profile preview

ShizimXL

Ownership: Private
Employees: ~20
Development stage: Other

Overview

ShizimXL invests in and accelerates early-stage MedTech and life science startups in Israel. Its model provides long-term support including mentoring by industry experts across regulatory affairs, clinical development, IP strategy, funding, business development and alliances with multinational players. The group has contributed to successful exits such as Microbot Medical's NASDAQ listing and XACT Robotics' FDA/CE approvals.

Therapeutic areas: OtherDermatologyNeurology
Modalities: Medical deviceDigital health technology
Industry: Investors

Partnerships

Global strategic partners in pharma/device sectors

Beyond the preview

Go deeper on ShizimXL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ShizimXL.

Explore the full profile